ValorSpine's evaluation for regenerative care combines medical history, advanced imaging, physical examination, and diagnostic injections to assess individual candidacy for intra-annular fibrin injection. Learn how each step works and what determines eligibility for biologic disc repair.

Veterans face spinal challenges from heavy loads, combat vibration, and high-impact service that conventional treatments often don't adequately address. Intra-annular fibrin injection and other regenerative options may help many veterans reduce chronic back pain without surgery. Candidacy is evaluated individually based on imaging findings and treatment history.

Compare epidural steroid injections and intra-annular fibrin injection for chronic back pain. Learn how each approach works, who may be a candidate, and why the distinction between symptom relief and structural repair matters for long-term outcomes.

Many patients with chronic back pain from annular tears may be candidates for biologic disc repair — but myths about eligibility often get in the way. Our clinical team clarifies who benefits, what evaluation involves, and what the evidence actually shows.

When epidural steroid injections provide only temporary relief, the underlying disc damage often goes unaddressed. Intra-annular fibrin injection is a biologic disc repair approach that targets annular tears directly — the structural source of many chronic pain cases. Learn how the procedure works, who may be a candidate, and what to expect at ValorSpine.

Spinal fusion and biologic disc repair represent two fundamentally different philosophies for chronic back pain. This comparison covers mechanism, recovery, risk profile, and candidacy to help patients ask better questions before committing to either path.

Regenerative spine care — including intra-annular fibrin injection — may offer a motion-preserving alternative to spinal fusion for patients with chronic discogenic pain. Learn who may qualify, how biologic disc repair works, and what to expect from an individualized evaluation at ValorSpine.